Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Matsuda Y, Tahara K, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Nakura M, Morita T, Yamaguchi T, Koyama A.
Matsuoka H, et al. Among authors: oyamada s.
Support Care Cancer. 2020 Jun;28(6):2931-2939. doi: 10.1007/s00520-019-05138-9. Epub 2019 Nov 25.
Support Care Cancer. 2020.
PMID: 31761974
Clinical Trial.